Skip to main content
iwCLL 2023 Main banner
Final Program


iwCLL X / Twitter
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Live Stream

(1549556) Bruton’s Tyrosine Kinase and Phospholipase C-Gamma 2 Mutational Profiles in Pooled Analysis of Patients With Chronic Lymphocytic Leukemia Treated With Ibrutinib

Sunday, October 8, 2023
12:05 PM – 12:15 PM EDT
Location: HCC, Ballroom ABC, Level 3

    Primary Author; Presenting Author(s)

  • Inhye E. Ahn, MD

    Assistant Professor
    Dana-Farber Cancer Institute
    Boston, MA, United States

    Slides

    • Co-Author(s)

  • Adrian Wiestner, MD, PhD

    Senior Investigator
    Laboratory of Lymphoid Malignancies, National Heart, Lung, and Blood Institute, National Institutes of Health
    Bethesda, MD, United States

  • Paolo Ghia, MD, PhD

    Professor of Medical Oncology
    Strategic Research Program on Chronic Lymphocytic Leukemia, Division of Experimental Oncology, IRCCS Ospedale San Raffaele and Università Vita-Salute San Raffaele, Milan, Italy
    Milan, Lombardia, Italy

  • JB

    John C. Byrd, MD

    University of Cincinnati College of Medicine
    Cincinnati, OH, United States

  • CM

    Carol Moreno, MD, PhD

    Hospital de la Santa Creu i Sant Pau, and the Josep Carreras Leukaemia Research Institute
    Barcelona, Spain

  • Susan M. O'Brien, MD

    Professor, Division of Hematology/Oncology
    Chao Family Comprehensive Cancer Center, University of California, Irvine
    Irvine, CA, United States

  • DJ

    Daniel Jones, MD, PhD

    The Ohio State University Comprehensive Cancer Center
    Columbus, OH, United States

  • VG

    Vincent Girardi, MA

    AbbVie Inc.
    North Chicago, IL, United States

  • LC

    Leo W.-K. Cheung, PhD

    AbbVie Inc.
    North Chicago, IL, United States

  • MA

    Melih Acar, PhD

    AbbVie Inc.
    North Chicago, IL, United States

  • SW

    Shiquan Wu, PhD

    AbbVie Inc.
    North Chicago, IL, United States

  • James P. Dean, MD, PhD

    Executive Medical Director Oncology
    AbbVie Inc.
    North Chicago, IL, United States

  • SP

    Sima Patel, PhD

    AbbVie Inc.
    North Chicago, IL, United States

  • Jennifer A. Woyach, MD

    Professor of Medicine
    Division of Hematology, Department of Internal Medicine, The Ohio State University
    The Ohio State University Comprehensive Cancer Center
    Columbus, OH, United States

Disclosure(s):
Inhye E. Ahn, MD: Astra Zeneca: Consultant, Advisor, Speaker (e.g., advisory boards, speakers’ bureaus) (Ongoing)
Jennifer A. Woyach, MD: No relevant disclosure to display